Men and women reporting overweight, respectively, are 19.14 and 11.44 times more likely to meet criteria for UPF addiction
Second COVID Infection in Children Doubles Risk for Long COVID
Heightened risk seen for many conditions, including myocarditis, blood clots, kidney damage, abnormal heart rhythms, headache, and fatigue
One in Four Individuals Will Develop Heart Failure in Their Lifetime
Evidence-based therapies remain underutilized in eligible patients
ASTRO: Stereotactic Arrhythmia RT Safer Than Repeat Catheter Ablation for High-Risk Ventricular Tachycardia
STAR recipients had superior median time of freedom from death, shock, or storm; more catheter ablation recipients developed serious adverse events
2015 to 2024 Saw Increase in Testing for Lipoprotein(a)
Increase reported in annual number of tested patients and percentage of total patient population tested, reaching 0.24 percent in 2024
Guidelines Issued for Vaccination as Part of Cardiovascular Care
Recommendations encourage flu, pneumococcal, COVID-19, RSV, and zoster vaccinations in individuals with cardiovascular disease
Globally, CVDs Were Leading Cause of Disability-Adjusted Life Years, Deaths in 2023
437 million CVD DALYs reported globally in 2023, representing a 1.4-fold increase from 1990; increase in number of CVD deaths also seen
GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis
Risk reductions stronger in those with psoriasis versus those with obesity or type 2 diabetes without psoriasis
Nonoptimal Levels of Traditional Risk Factors Almost Universal Before CVD
In both men and women, prevalence of one or more traditional risk factor before CVD was >99 percent across age groups
Prevention Strategies Developed for Cardiovascular Manifestations of COVID
Strategies include implementing targeted cardiovascular rehabilitation for those with acute and long COVID